Outcome of Board Meeting

Date: July 28, 2026 BSE Limited, National Stock Exchange of India Limited, 20th Floor, P.J. Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Bandra (E), Mumbai - 400001. Mumbai – 400 051 BSE Scrip Code: 544606 NSE Scrip Symbol: PINELABS Sub: Outcome of the Board Meeting held on July 28, 2026 Dear Sir/ Madam, Pursuant to Regulations 30, 33 and other applicable provisions of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with various circulars issued by the Securities and Exchange Board of India and Stock Exchanges and in furtherance to our intimation dated July 22, 2026, we enclose herewith the unaudited standalone and consolidated financial results of Pine Labs Limited (“the Company”) for the quarter ended June 30, 2026 ("Results") along with Limited Review Reports of B S R & Co. LLP, Statutory Auditor of the company and Press Release being issued in this regard. The said Results will also be published in the newspapers in the prescribed format. The Board Meeting to approve the said results commenced today i.e. on July 28, 2026, at 12:45 P.M. (IST) and concluded at 2:38 P.M. (IST). Further, kindly note that in terms of the Company’s Code of Conduct for Prevention of Insider Trading and the SEBI (Prohibition of Insider Trading) Regulations, 2015, the window for trading in Securities of the Company by its designated persons and their immediate relatives shall open on July 31, 2026. The above information will also be available on the website of the Company at www.pinelabs.com/investorrelations/financial-results?tab=quarterly-results. We request you to kindly take the above on record. Thanking you. For Pine Labs Limited Neerav Mehta Company Secretary and Compliance Officer Membership Number: A20949 Encl. a/a Building No. 10, 12th Floor, Tower-C B S R & CO_ LLP DLF Cyber City, Phas-e Il Gurugram - 122 002, India Chartered Accountants Tel: +91 124 719 1000 Fax: +91 124 235 8613 Limited Review Report on unaudited standalone financial results of Pine Labs Limited (formerly known as Pine Labs Private Limited) for the quarter ended 30 June 2026 pursuant to Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended To the Board of Directors of Pine Labs Limited (formerly known as Pine Labs Private Limited) 1. We have reviewed the accompanying Statement of unaudited standalone financial results of Pine Labs Limited (formerly known as Pine Labs Private Limited) (hereinafter referred to as “the Company”) for the quarter ended 30 June 2026 (“the Statement”). Attention is drawn to the fact that the figures for the corresponding quarter ended 30 June 2025, as reported in the Statement have been approved by the Company’s Board of Directors, but have not been subjected to review. 2. This Statement, which is the responsibility of the Company’s management and approved by its Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 “Interim Financial Reporting” (“Ind AS 34"), prescribed under Section 133 of the Companies Act, 2013, and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (“Listing Regulations”). Our responsibility is to issue a report on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 “Review of Interim Financial Information Performed by the Independent Auditor of the Entity”, issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. Attention is drawn to the fact that the figures for the three months ended 31 March 2026 as reported in the Statement are the balancing figures between audited figures in respect of the full previous financial year and the published year to date figures up to the third quarter of the previous financial year. The figures up to the end of the third quarter of previous financial year had only been reviewed and not subjected to audit. 5. Based on our review conducted as above, nothing has comteo our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standard and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the Listing Regulations, including the manner in which it is to be disclosed, or that it Regitered Offce: BSR 8 Co.(a partnership fi with Registration No. BAG1223) converted into 8 S R & Co. LLP (a 14th Floor,Central B Wing and North C Wing, Nesco IT Park 4, Nesco Limiteg Liabity Partnership with LLP Registration No. AAB-818w1i)t effectfrom October 14,2013 Center, Westem Express Highway, Goregaon (East), Mumbai - 400063 Page 10f 2 BSR&Co.LLP Limited Review Report (Continued) Pine Labs Limited (formerly known as Pine Labs Private Limited) contains any material misstatement. ForBSR & Co.LLP Chartered Accountants Firm’s Registration No.:101248W/W-100022 KUNAL g0 KAPUR %726 140043 40530 Kunal Kapur Partner Gurugram Membership No.: 509209 28 July 2026 UDIN:26509209EDTWOU6245 Page 2 of 2 Pine Labs Limited (formerly known as Pine Labs Private Limited) CIN: L67100HR1998PLC113312 Registered office: 4th Floor, Unit No. 408, Ti e Tower, MG Road, Gurugram, Haryana, 122002 Telephone: 0124-6949200, Email-investorrelations@pinelabs.com, Website-www.pinelabs.com Statement of standalone financial results for the quarter ended 30 June 2026 S.No [Particulars Quarter ended YVear ended 30 June 2026 | 31 March 2026] 30 June 2025 | 31 March 2026 Unaudited | Refernote3 |Refernote3and| Audited 1 [mcome Revenue from operations 535.00 51542 42727 1926.09 Other income 4801 56.81 4389 17229 Total income 583.01 572.23 2,098.38 2 |Expenses Transaction and related costs 8210 68.69 4519 244.66 Purchases of stock-in-trade 4181 60.28 1127 13267 Changes in inventories of stock-in-trade (249) (224) 247 (1.93) Employee benefits expense 19927 17126 20285 753.25 Finance costs 1043 1352 1875 7039 Depreciation and amortisation expenses 54.49 5131 4570 19221 Impairment of non-current assets 113 207 035 456 Impairment losses on financial assets & contract assets and bad debts 1001 342 808 2687 Other expenses 127.68 12260 11953 494.63 Total expenses 52447 490.91 45419 1917.31 3 [Proft before exceptional items and tax 58.54 8132 1697 181,07 Exceptional items (refer note 5) - (8.52) - 230 4 [Profit before tax 58.54 89.84 1697 178.77 5 |Tax expense Current tax 13.79 1427 - 1427 Deferred tax 1.09 828 11.19) 1462 Total tax expense/(credit) 14.88 22.55 (1.19) 28.89 6 [Profit for the period/year (4-5) 43.66 67.29 28.16 14988 7 |Other comprehensive income (OCI) Items that will not be reclassified subsequently to profit or loss Remeasurement of defined benefit liability (0.70) 425 (0.82) 071 Fair value changes on equity investments through OCI 432 - 679 679 Income tax relatintog these items (0.44)| (1.07)| 0.77)| (1.15) Other comprehensive income for the period/year, net of tax 318 318 520 635 8 [Total comprehensive income for the period/year 46.84 7047 33.36 156.23 9 |Paid-up equity share capital 11539 11483 4471 114.83 (face value of INR 1 per sh [Showing first 8,000 characters — download PDF for full document]